** Shares of medical equipment maker West Pharmaceutical WST.N rise 7.3% to $384.5 premarket

** West Pharma now expects 2026 adjusted profit per share to be between $8.85 and $9.05, compared with its prior view of $8.40 to $8.75 per share

** Expects its annual sales to be in the range of $3.35 billion to $3.38 billion, up from its previous forecast of $3.295 billion to $3.35 billion

** WST reports Q2 adjusted profit of $2.37 per share, above analysts' estimates of $2.08 per share - LSEG data

** Its quarterly revenue came in at $872.3 million, above analysts' expectations of $838.6 million

** As of last close, stock was up 30.3% YTD